Quantitative Systematic Strategies LLC Bausch Health Companies Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$15.31 - $21.12 $202,168 - $278,889	-13,205 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$14.88 - $20.13 $196,490 - $265,816	13,205 New	13,205 $205,000
Q1 2020 May 06, 2020	SELL	$12.98 - $30.25 $198,996 - $463,762	-15,331 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$18.89 - $31.89 $289,602 - $488,905	15,331 New	15,331 $459,000
Q3 2019 Nov 07, 2019	SELL	$20.88 - $25.66 $185,163 - $227,552	-8,868 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$20.52 - $26.45 $181,971 - $234,558	8,868 New	8,868 $224,000

264

250M

5.88M

9.78M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.23B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.